SRGN and Alzheimer disease: SRGN and SDC4 were over-expressed in most of the areas, and immunohistochemistry revealed the presence of SRGN in all three types of AD lesion: neuritic plaques, cerebral amyloid angiopathy, and neurofibrillary pre-tangles and tangles.